Crossmark

Efficacy of a group tobacco cessation behavioral intervention among tobacco users with concomitant mental illness in Kenya: protocol for a controlled clinical trial

Crossref DOI link: https://doi.org/10.1186/s12889-019-8040-2

Published Online: 2019-12-18

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Olando, Yvonne

Kuria, Mary

Mathai, Muthoni

Huffman, Mark D.
License Information

Text and Data Mining valid from 2019-12-01

Version of Record valid from 2019-12-18
More Information

Article History

Received: 12 June 2019

Accepted: 4 December 2019

First Online: 18 December 2019

Ethics approval and consent to participate

: The study received ethical approval clearance from the University of Nairobi/Kenyatta National Hospital Ethical Review Committee on the 28th February 2017 Ref: KNH-ERC/A/68, renewed on April 18 2018 Ref: KNH/ERC/R/87. All participants signed a consent form before participating in the study.

: Not applicable.

: YO, MM, MK declare that they have no competing interests. MDH has received grant support from the World Heart Federation to serve as its senior program advisor for the Emerging Leaders program, which is supported by unrestricted educational grants from Boehringer Ingelheim and Novartis with previous support from AstraZeneca and Bupa. MDH also receives support from the American Heart Association, Verily, and AstraZeneca and the American Medical Association for work unrelated to this project.

Document is current

Any future updates will be listed below